VEEVA SYSTEMS INC (VEEV) Stock
VEEV has an Alpha Score of 55 out of 100 (weak), computed on Oct 30, 2026 from 3 of 4 sub-scores. 6 members of Congress disclosed 10 trades in VEEV since 2018: 5 purchases and 5 sales, most recently Rob Bresnahan (purchase, May 29, 2025). 7 of the hedge funds AlphaScala tracks reported VEEV in 13F filings for the quarter ended Jun 30, 2026; the largest reported position is Fundsmith's at $144.95M. Company insiders reported 0 open-market buys and 11 sales on SEC Form 4 in the 90 days to Oct 30, 2026. Its trailing P/E ratio is 50.2 and its net margin 29.3% (key statistics as of Oct 22, 2026).
What is VEEV's Alpha Score?
How it works →Alpha Score of 55 reflects moderate overall profile with strong momentum, poor value, strong quality. Based on 3 of 4 signals – score is capped at 90 until remaining data ingests.
Computed from 3 of 4 sub-scores; a sub-score is left out when its inputs are missing, and the composite is capped accordingly.
Computed Oct 30, 2026
A rules-based research rating, not a recommendation to buy or sell.
Which members of Congress traded VEEVA SYSTEMS INC (VEEV)?
Most recent: Rob Bresnahan (purchase, May 29, 2025); records start Oct 17, 2018.
| Politician | Trade date | Type | Amount |
|---|---|---|---|
| Rob Bresnahan R-PA · House | 2025-05-29 | purchase | $1k – $15k |
| Rob Bresnahan R-PA · House | 2025-05-16 | sale | $1k – $15k |
| Byron Donalds R-FL · House | 2025-03-20 | sale | $1k – $15k |
| John James R-MI · House | 2024-07-16 | sale | $1k – $15k |
| John James R-MI · House | 2023-11-10 | purchase | $1k – $15k |
| Bill Keating D-MA · House | 2023-02-13 | purchase | $1k – $15k |
| Bill Keating D-MA · House | 2021-03-17 | purchase | $1k – $15k |
| Josh Gottheimer D-NJ · House | 2021-03-04 | sale | $1k – $15k |
From STOCK Act periodic transaction reports. House filings as of Oct 29, 2026.
See all VEEV political trades →Which hedge funds own VEEV?
From 13F filings| Fund | Shares Held | Position Value | Change vs prior Q |
|---|---|---|---|
| Fundsmith Terry Smith | 817K | $144.95M | NEW |
| Millennium Management Israel Englander | 271K | $48.05M | +390% |
| D.E. Shaw David Shaw | 129K | $22.90M | -87% |
| Citadel Ken Griffin | 65K | $11.49M | -57% |
| Bridgewater Associates Ray Dalio | 31K | $5.45M | NEW |
| Blackstone | 13K | $2.24M | NEW |
| Marshall Wace | 8K | $1.49M | -99% |
13F holdings as of Jun 30, 2026
Explore all tracked funds →Are VEEVA SYSTEMS INC insiders buying or selling?
SEC Form 4 filings| Date | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| Oct 14, 26 | Faddis Jonathan | SVP, Gen. Counsel, Secretary | SELL | 3.5K | $1.1M |
| Oct 14, 26 | Faddis Jonathan | SVP, Gen. Counsel, Secretary | SELL | 975 | $292K |
| Oct 14, 26 | Faddis Jonathan | SVP, Gen. Counsel, Secretary | SELL | 708 | $211K |
| Oct 2, 26 | Rizzo Daniel J | EVP, Sales, Consulting, & Svcs | SELL | 4.5K | $1.2M |
| Oct 2, 26 | Rizzo Daniel J | EVP, Sales, Consulting, & Svcs | SELL | 321 | $89K |
| Sep 14, 26 | Schwenger Thomas D. | Pres. & Chief Customer Officer | SELL | 1.0K | $265K |
| Sep 9, 26 | Hung Priscilla | Director | SELL | 750 | $196K |
| Aug 27, 26 | Schwenger Thomas D. | Pres. & Chief Customer Officer | SELL | 10.0K | $2.8M |
| Aug 13, 26 | Schwenger Thomas D. | Pres. & Chief Customer Officer | SELL | 1.0K | $242K |
| Aug 13, 26 | Schwenger Thomas D. | Pres. & Chief Customer Officer | SELL | 33.2K | $8.3M |
SEC Form 4 filings as of Oct 30, 2026
See cluster-buy signals across all tickers →What are VEEV's key statistics?
Key statistics as of Oct 22, 2026
How does VEEV's valuation compare with the Healthcare sector?
| Metric | VEEV | Healthcare median | Companies in median |
|---|---|---|---|
| P/E ratio | 50.2 | 27.1 | 97 |
| Net margin | 29.34% | 5.48% | 139 |
| Return on equity | 14.00% | 6.84% | 158 |
Medians over the Healthcare stocks whose key statistics were refreshed in the last 35 days (newest Nov 2, 2026). P/E excludes loss-making companies.
VEEV price chart
Powered by TradingViewWhat does VEEVA SYSTEMS INC do?
Veeva Systems Inc. is a leading provider of industry cloud solutions tailored for the global life sciences industry. The company offers cloud-based software, data solutions, and business consulting services that support critical functions from research and development through commercialization. Its flagship products include Veeva CRM, a customer relationship management platform that boosts productivity and compliance in sales and marketing for life sciences firms with salesforces, and Veeva Vault, a unified content management platform handling regulated documents, workflows, clinical trials, regulatory submissions, quality management, and safety reporting. Additional offerings encompass commercial cloud applications for multichannel marketing and analytics, real-world evidence collection, regulatory information management, and pharmacovigilance. Veeva Systems Inc. serves biotechnology, pharmaceutical, and medical device companies of all sizes across North America, Europe, Asia Pacific, Latin America, and beyond, ensuring compliance with regional regulations while enabling global collaboration and operational efficiency. Founded in 2007 and headquartered in Pleasanton, California, Veeva operates as a Public Benefit Corporation, leveraging modern multitenant cloud architecture to displace legacy systems.